Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.2900
-0.0100 (-3.33%)
At close: Mar 6, 2026

BOM:524661 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
3,655245.5--1.051.33
Revenue Growth (YoY)
994.82%----21.26%61.63%
Cost of Revenue
3,205205.05----
Gross Profit
450.4840.45--1.051.33
Selling, General & Admin
2.624.471.030.420.130.77
Other Operating Expenses
0.48.11-2.25-0.870.680.01
Operating Expenses
3.1612.65-0.86-0.410.810.78
Operating Income
447.3227.80.860.410.240.55
Interest & Investment Income
--0.580.44-0
Other Non Operating Income (Expenses)
14.64-0.01---0
EBT Excluding Unusual Items
461.9627.81.450.860.240.55
Gain (Loss) on Sale of Investments
---3.20.16--
Pretax Income
461.9627.8-1.751.020.240.55
Income Tax Expense
15.796.1----
Net Income
446.1721.7-1.751.020.240.55
Net Income to Common
446.1721.7-1.751.020.240.55
Net Income Growth
2262.32%--331.31%-57.24%-
Shares Outstanding (Basic)
1,718859149148133133
Shares Outstanding (Diluted)
1,718859149148133133
Shares Change (YoY)
78.83%477.75%0.54%10.90%--
EPS (Basic)
0.260.03-0.010.010.000.00
EPS (Diluted)
0.260.03-0.010.010.000.00
EPS Growth
1221.06%--284.56%-57.25%-
Free Cash Flow
--2,220-1.281.070.190.42
Free Cash Flow Per Share
--2.59-0.010.010.000.00
Gross Margin
12.32%16.48%--100.00%100.00%
Operating Margin
12.24%11.32%--22.46%41.26%
Profit Margin
12.21%8.84%--22.46%41.36%
Free Cash Flow Margin
--904.46%--17.67%31.64%
EBITDA
447.1827.881.220.44--
EBITDA Margin
12.23%11.36%----
D&A For EBITDA
-0.140.080.360.03--
EBIT
447.3227.80.860.410.240.55
EBIT Margin
12.24%11.32%--22.46%41.26%
Effective Tax Rate
3.42%21.94%----
Revenue as Reported
3,689264.60.942.371.051.34
Advertising Expenses
-0.07-0.02--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.